An ASK1-p38 signalling pathway mediates hydrogen peroxide-induced toxicity in NG108-15 neuronal cells

Neuroscience Letters

Volumn 549, Issue , 2013, Pages 163-167

  Nomura, Koji ^a   Lee, Mercede ^a   Banks, Christina ^a   Lee, Graham ^a,b   Morris, Brian J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Apoptosis; MAP kinase; Neurons; Reactive oxygen species

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; APOPTOSIS SIGNAL REGULATING KINASE 1; CASPASE 3; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE 7; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

APOPTOSIS; MAP KINASE; NEURONS; REACTIVE OXYGEN SPECIES;

ANIMALS; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; HYDROGEN PEROXIDE; MAP KINASE KINASE KINASE 5; MICE; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84880705436     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.05.045     Document Type: Article

References (52)

1. Arora K., Alfulaij N., Higa J.K., Panee J., Nichols R.A. Impact of sustained exposure to β-amyloid on calcium homeostasis and neuronal integrity in model nerve cell system expressing α4β2 nicotinic acetylcholine receptors. J. Biol. Chem. 2013, 288:11175-11190.
2. Barberan S., McNair K., Iqbal K., Smith N.C., Prendergast G.C., Stone T.W., Cobb S.R., Morris B.J. Altered apoptotic responses in neurons lacking RhoB GTPase. Eur. J. Neurosci. 2011, 34:1737-1746.
3. Barros-Miñones L., Orejana L., Goñi-Allo B., Suquía V., Hervías I., Aguirre N., Puerta E. Modulation of the ASK1-MKK3/6-p38/MAPK signalling pathway mediates sildenafil protection against chemical hypoxia caused by malonate. Br. J. Pharmacol. 2012, 168:1820-1834.
4. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13681-13686.
5. Burr P., Morris B.J. Involvement of NMDA receptors and a p21Ras-like guanosine triphosphatase in the constitutive activation of nuclear factor-kappa-B in cortical neurons. Exp. Brain Res. 2002, 147:273-279.
6. 2+]i in NG108-15 cells subjected to high strain rate deformation and chemical hypoxia: an in vitro model for neural trauma. J. Neurotrauma. 1996, 13:395-407.
7. 2+ store depletion and endoplasmic reticulum stress are involved in P2X7 receptor-mediated neurotoxicity in differentiated NG108-15 cells. J. Cell. Biochem. 2012, 113:1377-1385.
8. Chen L., Liu L., Yin J., Luo Y., Huang S. Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway. Int. J. Biochem. Cell Biol. 2009, 41:1284-1295.
9. Choi K., Kim J.H., Kim G.W., Choi C. Oxidative stress-induced necrotic cell death via mitochondria-dependent burst of reactive oxygen species. Curr. Neurovasc. Res. 2009, 6:213-222.
10. Choo M.-K., Kawasaki N., Singhirunnusorn P., Koizumi K., Sato S., Akira S., Saiki I., Sakurai H. Blockade of transforming growth factor-β-activated kinase 1 activity enhances TRAIL-induced apoptosis through activation of a caspase cascade. Mol. Cancer Ther. 2006, 5:2970-2976.
11. Circu M.L., Aw T.Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic. Biol. Med. 2010, 48:749-762.
12. Clark K., Peggie M., Plater L., Sorcek R.J., Young E.R.R., Madwed J.B., Hough J., McIver E.G., Cohen P. Novel cross-talk within the IKK family controls innate immunity. Biochem. J. 2011, 434:93-104.
13. 2+ and PI3-kinase. J. Neurochem. 2002, 80:24-35.
14. Cruise L., Ho L.K., Veitch K., Fuller G., Morris B.J. Kainate receptors activate NFkB via MAP kinase in striatal neurones. Neuroreport 2000, 11:395-401.
15. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 2001, 351:95-105.
16. Ebenezer P.J., Weidner A.M., LeVine I.I.I.H., Markesbery W.R., Murphy M.P., Zhang L., Dasuri K., Fernandez-Kim S.O., Bruce-Keller A.J., Gavilán E., Keller J.N. Neuron specific toxicity of oligomeric amyloid-β: role for JUN-kinase and oxidative stress. J. Alzheimer's Dis. 2010, 22:839-848.
17. Fuller G., Veitch K., Lai Kwan H., Cruise L., Morris B.J. Activation of p44/p42 MAP kinase in striatal neurons via kainate receptors and PI3 kinase. Mol. Brain Res. 2001, 89:126-132.
18. Hammaker D., Boyle D., Inoue T., Firestein G. Regulation of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis synoviocytes. Arthritis Res. Ther. 2007, 9:R57.
19. Harada C., Nakamura K., Namekata K., Okumura A., Mitamura Y., Iizuka Y., Kashiwagi K., Yoshida K., Ohno S., Matsuzawa A., Tanaka K., Ichijo H., Harada T. Role of apoptosis signal-regulating kinase 1 in stress-induced neural cell apoptosis in vivo. Am. J. Pathol. 2006, 168:261-269.
20. Holasek S.S., Wengenack T.M., Kandimalla K.K., Montano C., Gregor D.M., Curran G.L., Poduslo J.F. Activation of the stress-activated MAP kinase p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice. Brain Res. 2005, 1045:185-198.
21. Homma K., Katagiri K., Nishitoh H., Ichijo H. Targeting ASK1 in ER stress-related neurodegenerative diseases. Expert Opin. Ther. Targets 2009, 13:653-664.
22. James A.B., Conway A.-M., Morris B.J. Regulation of the neuronal proteasome by Zif268 (Egr1). J. Neurosci. 2006, 26:1624-1634.
23. Johansson T., Elfverson M., Birgner C., Frändberg P.-A., Nyberg F., Le P., Grevès Neurosteroids alter glutamate-induced changes in neurite morphology of NG108-15 cells. J. Steroid Biochem. Mol. Biol. 2007, 104:215-219.
24. Katome T., Namekata K., Guo X., Semba K., Kittaka D., Kawamura K., Kimura A., Harada C., Ichijo H., Mitamura Y., Harada T. Inhibition of ASK1-p38 pathway prevents neural cell death following optic nerve injury. Cell Death Differ. 2013, 20:270-280.
25. Kim E.K., Choi E.-J. Pathological roles of MAPK signaling pathways in human diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2010, 1802:396-405.
26. Kim S.D., Moon C.K., Eun S.-Y., Ryu P.D., Jo S.A. Identification of ASK1, MKK4, JNK, c-Jun, and caspase-3 as a signaling cascade involved in cadmium-induced neuronal cell apoptosis. Biochem. Biophys. Res. Commun. 2005, 328:326-334.
27. Kim S.Y., Shim J.-H., Chun E., Lee K.-Y. Reciprocal inhibition between the transforming growth factor-β-activated kinase 1 (TAK1) and apoptosis signal-regulating kinase 1 (ASK1) mitogen-activated protein kinase kinase kinases and its suppression by TAK1-binding protein 2 (TAB2), an adapter protein for TAK1. J. Biol. Chem. 2012, 287:3381-3391.
28. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 2001, 81:807-869.
29. Lamothe B., Lai Y., Xie M., Schneider M.D., Darnay B.G. TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis. Mol. Cell. Biol. 2013, 33:582-595.
30. Liu A.Y.C., Mathur R., Mei N., Langhammer C.G., Babiarz B., Firestein B.L. Neuroprotective drug riluzole amplifies the heat shock factor 1 (HSF1)- and glutamate transporter 1 (GLT1)-dependent cytoprotective mechanisms for neuronal survival. J. Biol. Chem. 2011, 286:2785-2794.
31. 2-induced oxidative cell damage in NG108-15 cells. Biol. Pharm. Bull. 2003, 26:725-728.
32. 2-induced neuronal apoptosis. J. Neurochem. 1999, 73:1181-1188.
33. McDermott C.J., Bradley K.N., McCarron J.G., Palmer A.M., Morris B.J. Striatal neurones show sustained recovery from severe hypoglycaemic insult. J. Neurochem. 2003, 86:383-393.
34. McNair K., Spike R., Guilding C., Prendergast G.C., Stone T.W., Cobb S.R., Morris B.J. A role for RhoB in synaptic plasticity and the regulation of neuronal morphology. J. Neurosci. 2010, 30:3508-3517.
35. McNeer J.L., Goussetis D.J., Sassano A., Dolniak B., Kroczynska B., Glaser H., Altman J.K., Platanias L.C. Arsenic trioxide-dependent activation of thousand-and-one amino acid kinase 2 and transforming growth factor-β-activated kinase 1. Mol. Pharmacol. 2010, 77:828-835.
36. Muller D., Greenland K.J., Speth R.C., Middendorff R. Neuronal differentiation of NG108-15 cells has impact on nitric oxide- and membrane (natriuretic peptide receptor-A) cyclic GMP-generating proteins. Mol. Cell. Endocrinol. 2010, 320:118-127.
37. Neubert M., Ridder D.A., Bargiotas P., Akira S., Schwaninger M. Acute inhibition of TAK1 protects against neuronal death in cerebral ischemia. Cell Death Differ. 2011, 18:1521-1530.
38. Ninomiya-Tsuji J., Kajino T., Ono K., Ohtomo T., Matsumoto M., Shiina M., Mihara M., Tsuchiya M., Matsumoto K. A resorcylic acid lactone, 5Z-7-oxozeaenol prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J. Biol. Chem. 2003, 278:18485-18490.
39. Omori E., Morioka S., Matsumoto K., Ninomiya-Tsuji J. TAK1 regulates reactive oxygen species and cell death in keratinocytes, which is essential for skin integrity. J. Biol. Chem. 2008, 283:26161-26168.
40. Seidman K.J.N., Barsuk J.H., Johnson R.F., Weyhenmeyer J.A. Differentiation of NG108-15 neuroblastoma cells by serum starvation or dimethyl sulfoxide results in marked differences in angiotensin II receptor subtype expression. J. Neurochem. 1996, 66:1011-1018.
41. Shim J.-H., Xiao C., et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 2005, 19:2668-2681.
42. Simpson C.S., Morris B.J. Regulation of neuronal cell adhesion molecule (NCAM) expression by NF-κB. J. Biol. Chem. 2000, 275:16879-16884.
43. Singh A., Sweeney Michael.F., Yu M., Burger A., Greninger P., Benes C., Daniel A., Haber, Settleman J. TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers. Cell 2012, 148:639-650.
44. 2-induced cell damage by increasing glutathione levels in NG108-15 cells. Brain Res. 2001, 889:225-228.
45. Tobiume K., Matsuzawa A., Takahashi T., Nishitoh H., Morita K., Takeda K., Minowa O., Miyazono K., Noda T., Ichijo H. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2001, 2:222-228.
46. Vauzour D., Vafeiadou K., Rice-Evans C., Williams R.J., Spencer J.P.E. Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J. Neurochem. 2007, 103:1355-1367.
47. Volynets G.P., Chekanov M.O., Synyugin A.R., Golub A.G., Kukharenko O.P., Bdzhola V.G., Yarmoluk S.M. Identification of 3H-naphtho[1,2,3-de]quinoline-2,7-diones as inhibitors of apoptosis signal-regulating kinase 1 (ASK1). J. Med. Chem. 2011, 54:2680-2686.
48. Wang Y., Huang G., Vogel P., Neale G., Reizis B., Chi H. Transforming growth factor beta-activated kinase 1 (TAK1)-dependent checkpoint in the survival of dendritic cells promotes immune homeostasis and function. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E343-E352.
49. White B.J., Tarabishy S., Venna V.R., Manwani B., Benashski S., McCullough L.D., Li J. Protection from cerebral ischemia by inhibition of TGFβ-activated kinase. Exp. Neurol. 2012, 237:238-245.
50. Yamaguchi K., Shirakabe K., Shibuya H., Irie K., Oishi I., Ueno N., Taniguchi T., Nishida E., Matsumoto K. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 1995, 270:2008-2011.
51. Yang L., Inokuchi S., Roh Y.S., Song J., Loomba R., Park E.J., Seki E. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1. Gastroenterology 2013, 144:1042-1054.
52. 2 exposure involves scavenging ROS and inhibition JNK phosphorylation. J. Neurochem. 2009, 111:441-451.